{"transactions":[{"id":1072,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:34:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9579,"source":{"system":"sec-edgar","filing":"0001756253-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756253/000175625326000009/edgardoc.xml","form_type":"4"}},{"id":1071,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:34:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.6443,"value":3425.0202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":11271,"source":{"system":"sec-edgar","filing":"0001756253-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756253/000175625326000009/edgardoc.xml","form_type":"4"}},{"id":692945,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:46:06.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":11285,"source":{"system":"sec-edgar","filing":"0001756253-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000175625326000006/edgardoc.xml","form_type":"4"}},{"id":725407,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-26T20:22:12.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":19290,"price":9.59,"value":184991.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders. Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (a) 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (b) five years from the date of grant of the deferred RSUs."}],"balance_after":56643,"source":{"system":"sec-edgar","filing":"0001412408-26-000184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000141240826000184/form4.xml","form_type":"4"}},{"id":733764,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-17T20:45:12.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1157,"price":230.55,"value":266746.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on March 9, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":9680,"source":{"system":"sec-edgar","filing":"0001756253-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000175625326000004/edgardoc.xml","form_type":"4"}},{"id":767905,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-21T21:14:28.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":30441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":30441,"derivative":{"underlying":"Common Stock","underlying_shares":30441},"source":{"system":"sec-edgar","filing":"0001756253-26-000002","document":"wk-form4_1779398065.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000175625326000002/wk-form4_1779398065.xml","form_type":"4"}},{"id":1069959,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:36:09.000Z","date":"2025-08-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1805,"price":111.2502,"value":200806.611,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":10837,"source":{"system":"sec-edgar","filing":"0001765581-25-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000080/edgardoc.xml","form_type":"4"}},{"id":1069958,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:36:09.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":3507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026."}],"balance_after":12642,"source":{"system":"sec-edgar","filing":"0001765581-25-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000080/edgardoc.xml","form_type":"4"}},{"id":1092149,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-07-03T23:34:23.000Z","date":"2025-07-02","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":51193,"derivative":{"exercise_price":4.71,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001127602-25-018936","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760225018936/form4.xml","form_type":"4"}},{"id":1092148,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-03T23:34:23.000Z","date":"2025-07-02","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":29,"value":203000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 10, 2025."}],"balance_after":37353,"source":{"system":"sec-edgar","filing":"0001127602-25-018936","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760225018936/form4.xml","form_type":"4"}},{"id":1092147,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-03T23:34:23.000Z","date":"2025-07-02","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":4.71,"value":32970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 10, 2025."}],"balance_after":44353,"source":{"system":"sec-edgar","filing":"0001127602-25-018936","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760225018936/form4.xml","form_type":"4"}},{"id":1100118,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-27T22:44:42.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":6700,"price":27.61,"value":184987.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 25, 2026 and (ii) the next annual meeting of the Issuer's stockholders. Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (a) 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (b) five years from the date of grant of the deferred RSUs."}],"balance_after":37353,"source":{"system":"sec-edgar","filing":"0001127602-25-018206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760225018206/form4.xml","form_type":"4"}},{"id":1135235,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T20:07:03.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":28986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":28986,"derivative":{"underlying":"Common Stock","underlying_shares":28986},"source":{"system":"sec-edgar","filing":"0001477449-25-000070","document":"wk-form4_1748030815.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744925000070/wk-form4_1748030815.xml","form_type":"4"}},{"id":1429284,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T20:10:41.000Z","date":"2024-08-15","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":7.078,"value":28312.0,"ownership":{"direct":true},"balance_after":8355,"source":{"system":"sec-edgar","filing":"0001628280-24-037693","document":"wk-form4_1724098235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000162828024037693/wk-form4_1724098235.xml","form_type":"4"}},{"id":1439506,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T22:42:03.000Z","date":"2024-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1484,"price":111.35,"value":165243.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9135,"source":{"system":"sec-edgar","filing":"0001765581-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000078/edgardoc.xml","form_type":"4"}},{"id":1439505,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T22:42:03.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":3731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025."}],"balance_after":10619,"source":{"system":"sec-edgar","filing":"0001765581-24-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000078/edgardoc.xml","form_type":"4"}},{"id":1450412,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-07-22T20:56:15.000Z","date":"2024-07-18","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable as of the date hereof."}],"balance_after":58193,"derivative":{"exercise_price":4.71,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001127602-24-020800","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760224020800/form4.xml","form_type":"4"}},{"id":1450411,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-22T20:56:15.000Z","date":"2024-07-18","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":25,"value":175000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2023."}],"balance_after":30653,"source":{"system":"sec-edgar","filing":"0001127602-24-020800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760224020800/form4.xml","form_type":"4"}},{"id":1450410,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-22T20:56:15.000Z","date":"2024-07-18","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":4.71,"value":32970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2023."}],"balance_after":37653,"source":{"system":"sec-edgar","filing":"0001127602-24-020800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760224020800/form4.xml","form_type":"4"}},{"id":1467121,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-28T21:04:55.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":8490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 26, 2025 and (ii) the next annual meeting of the Issuer's stockholders.  Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (a) 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (b) five years from the date of grant of the deferred RSUs."}],"balance_after":30653,"source":{"system":"sec-edgar","filing":"0001127602-24-019403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000112760224019403/form4.xml","form_type":"4"}},{"id":1501936,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-24T20:26:54.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":17467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":17467,"derivative":{"underlying":"Common Stock","underlying_shares":17467},"source":{"system":"sec-edgar","filing":"0001477449-24-000126","document":"wk-form4_1716582399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000126/wk-form4_1716582399.xml","form_type":"4"}},{"id":1719936,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-12-06T21:39:43.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":417,"price":119.27,"value":49735.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6888,"source":{"system":"sec-edgar","filing":"0001765581-23-000110","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000110/edgardoc.xml","form_type":"4"}},{"id":1807128,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T22:00:22.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":1241,"price":138.1579,"value":171453.9539,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.63 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7305,"source":{"system":"sec-edgar","filing":"0001765581-23-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000090/edgardoc.xml","form_type":"4"}},{"id":1807127,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T22:00:22.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":3075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024."}],"balance_after":8546,"source":{"system":"sec-edgar","filing":"0001765581-23-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000090/edgardoc.xml","form_type":"4"}},{"id":1840995,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-30T20:15:27.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":6051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 28, 2024, and (ii) the next annual meeting of the Issuer's stockholders. Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (a) 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (b) five years from the date of grant of the deferred RSUs."}],"balance_after":22163,"source":{"system":"sec-edgar","filing":"0001562180-23-005580","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000156218023005580/primarydocument.xml","form_type":"4"}},{"id":1876437,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-26T20:39:42.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":9834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":9834,"derivative":{"underlying":"Common Stock","underlying_shares":9834},"source":{"system":"sec-edgar","filing":"0001415889-23-008862","document":"form4-05262023_080501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000141588923008862/form4-05262023_080501.xml","form_type":"4"}},{"id":1924852,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-04-05T20:36:11.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 18, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"27,306 of the original 84,193 shares underlying the option vested became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019, and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":65193,"derivative":{"exercise_price":4.71,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001562180-23-003442","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000156218023003442/primarydocument.xml","form_type":"4"}},{"id":1924851,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T20:36:11.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":500,"price":31.771,"value":15885.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 18, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $31.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16112,"source":{"system":"sec-edgar","filing":"0001562180-23-003442","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000156218023003442/primarydocument.xml","form_type":"4"}},{"id":1924850,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T20:36:11.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":30.6895,"value":199481.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 18, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.33 to $31.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16612,"source":{"system":"sec-edgar","filing":"0001562180-23-003442","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000156218023003442/primarydocument.xml","form_type":"4"}},{"id":1924849,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T20:36:11.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":4.71,"value":32970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 18, 2023."}],"balance_after":23112,"source":{"system":"sec-edgar","filing":"0001562180-23-003442","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000156218023003442/primarydocument.xml","form_type":"4"}},{"id":2094289,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-12-06T23:57:15.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":420,"price":154.6806,"value":64965.852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":5471,"source":{"system":"sec-edgar","filing":"0001765581-22-000130","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000130/edgardoc.xml","form_type":"4"}},{"id":2190636,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:42:05.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":1089,"price":152.3225,"value":165879.2025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":5891,"source":{"system":"sec-edgar","filing":"0001765581-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000098/edgardoc.xml","form_type":"4"}},{"id":2190635,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:42:05.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023."}],"balance_after":6980,"source":{"system":"sec-edgar","filing":"0001765581-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000098/edgardoc.xml","form_type":"4"}},{"id":2214469,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-05T21:46:30.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":7397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 30, 2023, and (ii) the next annual meeting of the Issuer's stockholders.  Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (i) 90 days after Director ceases to serve as a member of the Board of Directors of the Issuer and incurs a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder or (ii) five years from the date of grant of the deferred RSUs."}],"balance_after":16112,"source":{"system":"sec-edgar","filing":"0001562180-22-005519","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000156218022005519/primarydocument.xml","form_type":"4"}},{"id":2251480,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-31T20:14:46.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":6726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":6726,"derivative":{"underlying":"Common Stock","underlying_shares":6726},"source":{"system":"sec-edgar","filing":"0001415889-22-005894","document":"form4-05312022_010536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000141588922005894/form4-05312022_010536.xml","form_type":"4"}},{"id":2265599,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-18T20:20:45.000Z","date":"2022-05-17","kind":"exercise","acquired":false,"shares":819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":819,"derivative":{"underlying":"Common Stock","underlying_shares":819},"source":{"system":"sec-edgar","filing":"0001415889-22-005235","document":"form4-05182022_010508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000141588922005235/form4-05182022_010508.xml","form_type":"4"}},{"id":2265598,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:20:45.000Z","date":"2022-05-17","kind":"exercise","acquired":true,"shares":819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."}],"balance_after":4355,"source":{"system":"sec-edgar","filing":"0001415889-22-005235","document":"form4-05182022_010508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000141588922005235/form4-05182022_010508.xml","form_type":"4"}},{"id":2483548,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-12-07T00:17:02.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":417,"price":121.3,"value":50582.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":4419,"source":{"system":"sec-edgar","filing":"0001765581-21-000133","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000133/edgardoc.xml","form_type":"4"}},{"id":2619824,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-02T22:27:17.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":2246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022."}],"balance_after":4836,"source":{"system":"sec-edgar","filing":"0001765581-21-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000083/edgardoc.xml","form_type":"4"}},{"id":2636019,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-12T20:30:34.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":2605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) July 8, 2022, and (ii) the next annual meeting of the Issuer's stockholders. Director has elected to defer this grant pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (i) 90 days after Director ceases to serve as a member of the Board of Directors of the Issuer and incurs a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder or (ii) five years from the date of grant of the deferred RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes RSUs. Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":8715,"source":{"system":"sec-edgar","filing":"0001562180-21-004894","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000156218021004894/primarydocument.xml","form_type":"4"}},{"id":2708023,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-18T20:18:37.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":1638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":1638,"derivative":{"underlying":"Common Stock","underlying_shares":1638},"source":{"system":"sec-edgar","filing":"0001179110-21-005495","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021005495/edgar.xml","form_type":"4"}},{"id":2708022,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-18T20:18:37.000Z","date":"2021-05-14","kind":"exercise","acquired":false,"shares":524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 28, 2020, the reporting person was granted 1,049 restricted stock units, vesting in full on May 17, 2021. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 28, 2020, the reporting person was granted 1,049 restricted stock units, vesting in full on May 17, 2021. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":525,"derivative":{"underlying":"Common Stock","underlying_shares":524},"source":{"system":"sec-edgar","filing":"0001179110-21-005495","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021005495/edgar.xml","form_type":"4"}},{"id":2708021,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-18T20:18:37.000Z","date":"2021-05-14","kind":"exercise","acquired":true,"shares":524,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."}],"balance_after":3536,"source":{"system":"sec-edgar","filing":"0001179110-21-005495","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911021005495/edgar.xml","form_type":"4"}},{"id":2825849,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-01T22:01:59.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest 1/3 on December 1, 2021 and in 24 equal monthly installments thereafter."}],"balance_after":6475,"derivative":{"exercise_price":170.74,"expiration_date":"2031-02-24","underlying":"Ordinary Shares","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001765581-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000011/edgardoc.xml","form_type":"4"}},{"id":2825848,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-01T22:01:59.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":2590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in equal annual installments over three years measured from the vesting commencement date of December 1, 2020, with 1/3 vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent two years."}],"balance_after":2590,"source":{"system":"sec-edgar","filing":"0001765581-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000011/edgardoc.xml","form_type":"4"}},{"id":2916222,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T01:34:22.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"27,306 options vested and became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019 and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":72193,"derivative":{"exercise_price":4.71,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-21-000766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924321000766/doc4.xml","form_type":"4"}},{"id":2916221,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:34:22.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":300,"price":54.0633,"value":16218.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.63 to $54.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes Restricted Stock Units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":6110,"source":{"system":"sec-edgar","filing":"0000899243-21-000766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924321000766/doc4.xml","form_type":"4"}},{"id":2916220,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:34:22.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2789,"price":52.9312,"value":147625.1168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.60 to $53.43 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes Restricted Stock Units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":6410,"source":{"system":"sec-edgar","filing":"0000899243-21-000766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924321000766/doc4.xml","form_type":"4"}},{"id":2916219,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:34:22.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2911,"price":52.0669,"value":151566.7459,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.60 to $52.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes Restricted Stock Units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":9199,"source":{"system":"sec-edgar","filing":"0000899243-21-000766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924321000766/doc4.xml","form_type":"4"}},{"id":2916218,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:34:22.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":6000,"price":4.71,"value":28260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes Restricted Stock Units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":12110,"source":{"system":"sec-edgar","filing":"0000899243-21-000766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924321000766/doc4.xml","form_type":"4"}},{"id":3060528,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-12T22:01:26.000Z","date":"2020-08-10","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"27,306 options vested and became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019 and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":78193,"derivative":{"exercise_price":4.71,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-20-022171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320022171/doc4.xml","form_type":"4"}},{"id":3060527,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-12T22:01:26.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":6000,"price":30.3041,"value":181824.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.73 to $30.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes Restricted Stock Units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":6110,"source":{"system":"sec-edgar","filing":"0000899243-20-022171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320022171/doc4.xml","form_type":"4"}},{"id":3060526,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-12T22:01:26.000Z","date":"2020-08-10","kind":"exercise","acquired":true,"shares":6000,"price":4.71,"value":28260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes Restricted Stock Units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock."}],"balance_after":12110,"source":{"system":"sec-edgar","filing":"0000899243-20-022171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320022171/doc4.xml","form_type":"4"}},{"id":3079027,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T22:53:58.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":6110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) July 8, 2021, and (ii) the next annual meeting of the Issuer's stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of RSUs."}],"balance_after":6110,"source":{"system":"sec-edgar","filing":"0000899243-20-019833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320019833/doc4.xml","form_type":"4"}},{"id":3129023,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-01T20:15:13.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":1049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death."}],"balance_after":1049,"derivative":{"underlying":"Common Stock","underlying_shares":1049},"source":{"system":"sec-edgar","filing":"0001179110-20-006750","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911020006750/edgar.xml","form_type":"4"}},{"id":3129022,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-01T20:15:13.000Z","date":"2020-05-28","kind":"exercise","acquired":false,"shares":3012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 30, 2019, the reporting person was granted 3,012 restricted stock units, vesting in full on May 28, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 30, 2019, the reporting person was granted 3,012 restricted stock units, vesting in full on May 28, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3012},"source":{"system":"sec-edgar","filing":"0001179110-20-006750","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911020006750/edgar.xml","form_type":"4"}},{"id":3129021,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-01T20:15:13.000Z","date":"2020-05-28","kind":"exercise","acquired":true,"shares":3012,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."}],"balance_after":3012,"source":{"system":"sec-edgar","filing":"0001179110-20-006750","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911020006750/edgar.xml","form_type":"4"}},{"id":3504678,"issuer":{"id":1547,"kind":"organization","name":"Teladoc Health, Inc.","symbol":"TDOC"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-03T20:04:42.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":3012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders."}],"balance_after":3012,"derivative":{"underlying":"Common Stock","underlying_shares":3012},"source":{"system":"sec-edgar","filing":"0001179110-19-006979","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477449/000117911019006979/edgar.xml","form_type":"4"}}]}